OSAM
OCDX

O'Shaughnessy Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,714
Closed -$58K – 2914
2021
Q2 		$58K Buy
+2,714
New +$55.2K ﹤0.01% 1529

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

O'Shaughnessy Asset Management's OCDX Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q3 2021, closing a stake of 2,714 shares — an estimated $58K sold.

O'Shaughnessy Asset Management first reported a position in OCDX in Q2 2021 and held it in 1 quarter. The position peaked at $58K in Q2 2021. 140 funds tracked by Wall St. Rank hold OCDX as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2,714 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q3 2021, an estimated $58K.
  • O'Shaughnessy Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $58K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.